| abstract |
An object of the present invention is to provide administration of lorcaserine to an individual having a renal defect. The present disclosure determines the level of normal function of the kidneys of an individual and a therapeutically effective amount of (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-. It relates to a method of weight management in an individual in need of weight management by formulating or administering to the individual 3-benzazepine or a pharmaceutically acceptable salt, solvate or hydrate thereof. However, the individual has a level of normal kidney function selected from the group consisting of absence of kidney defects, mild kidney defects, and moderate kidney defects. [Selection] Figure 1A |